Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in CADL — Candel Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in CADL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$547,408
-$136,264 QoQ
Shares Held
111,716
-7.7% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. CADL ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CADL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $547,408 111,716
2025-12-31 $683,672 121,004
2025-09-30 $617,120 121,004
2025-06-30 $575,686 113,772
2025-03-31 $473,922 83,880
2024-12-31 $453,009 52,190
2024-09-30 $324,164 46,777
2024-06-30 $290,017 46,777